Reflections on Medicine and Life by Dr. S.P. Kalantri
Clinical stories and reflections on evidence-based medicine, research, and patient care.
High hospital bills and black marketing of drugs and oxygen make the treatment of Covid-19 prohibitively expensive. Malini Aisola, co-convenor of the All India Drug Action Network, ET’s Kiran Somvanshi and I discuss the flaws in the existing setup and the steps to fix the financial burden of Covid-19.
How do we deal with Covid-19 in Indian villages? We must empower primary health centres, where people are familiar with the doctors and healthcare workers; provide adequate training and resources; and weed out unnecessary drugs and investigations. Also, make vaccinations available close to people’s homes. I speak to Indiaspend.
I couldn’t believe my eyes. So I asked my colleague to read to me the recent COVID-19 guidelines from the Directorate General of Health Services (DGHS), in the Union health ministry. I couldn’t believe my ears either. The nine-page PDF document talks about how to treat, investigate and monitor patients with a COVID-19 infection. What are the … Read more
Remdesivir. Hydroxychloroquine apart, no drug during the current pandemic created as much controversy, generated as much hope, led to as much black marketing and eniced as many physicians and people as Remdesivir did. I was not sure if remdesivir indeed reduced the chances of dying in hospitalised patients and wondered if the hype and hope … Read more
Exactly a year ago, on this very date, a 64-year-old person arrived in the repurposed Covid block of Sevagram. He hailed from Washim—a town 225 km south-west of Sevagram—tested positive in the neighbouring medical school and was admitted to what was once a Medicine ICU. He was the first patient in our Covid ICU, the … Read more